We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AISP
326
Airship AI Holdings
AISP
$66.1M
$3.86M 0.03%
+399,804
New +$3.88M
MIT
327
DELISTED
Mason Industrial Technology, Inc.
MIT
$3.85M 0.03%
+398,799
New +$3.88M
GHAC
328
DELISTED
Gaming & Hospitality Acquisition Corp. Class A Common Stock
GHAC
$3.85M 0.03%
+399,591
New +$3.91M
COIN icon
329
Coinbase
COIN
$38.4B
$3.8M 0.03%
+15,000
New +$3.89M
TACA
330
DELISTED
Trepont Acquisition Corp I
TACA
$3.8M 0.03%
384,171
AVAN
331
DELISTED
Avanti Acquisition Corp.
AVAN
$3.8M 0.03%
389,870
-110,112
-22% -$1.08M
VST icon
332
Vistra
VST
$47.7B
$3.71M 0.03%
200,000
FAF icon
333
First American
FAF
$7.67B
$3.64M 0.03%
+58,450
New +$3.72M
BOAC
334
DELISTED
Bluescape Opportunities Acquisition Corp.
BOAC
$3.63M 0.03%
370,368
-129,614
-26% -$1.28M
AVB icon
335
AvalonBay Communities
AVB
$26.6B
$3.63M 0.03%
+17,400
New +$3.48M
TSM icon
336
TSMC
TSM
$2.17T
$3.6M 0.03%
30,000
NGCA
337
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
$3.59M 0.03%
+349,021
New +$3.5M
STAG icon
338
STAG Industrial
STAG
$7.1B
$3.56M 0.03%
+95,100
New +$3.47M
TRONU
339
DELISTED
Corner Growth Acquisition Corp. 2 Units
TRONU
$3.54M 0.03%
+351,370
New +$3.54M
ESS icon
340
Essex Property Trust
ESS
$18.3B
$3.48M 0.03%
11,600
+8,600
+287% +$2.54M
DOC icon
341
Healthpeak Properties
DOC
$14.5B
$3.46M 0.03%
104,070
+27,870
+37% +$935K
ULTA icon
342
Ulta Beauty
ULTA
$23.2B
$3.46M 0.03%
+10,000
New +$3.28M
CAS
343
DELISTED
Cascade Acquisition Corp.
CAS
$3.45M 0.03%
349,395
-150,587
-30% -$1.49M
AAL icon
344
PUT
American Airlines Group
AAL
$10.6B
$3.45M 0.03%
4,796,300
-3,106,700
-39% -$70.3M
CLVT icon
345
Clarivate
CLVT
$1.18B
$3.44M 0.03%
+125,000
New +$3.44M
VEI
346
DELISTED
Vine Energy Inc.
VEI
$3.44M 0.03%
+220,358
New +$3.03M
LVRA
347
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$3.42M 0.03%
+350,000
New +$3.43M
SCOA
348
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
$3.41M 0.03%
349,395
-150,587
-30% -$1.48M
HCII
349
DELISTED
Hudson Executive Investment Corp. II Class A Common Stock
HCII
$3.4M 0.03%
350,383
+100,392
+40% +$987K
AONC
350
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$3.4M 0.03%
+350,229
New +$3.43M

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.